Cyclic Cationic Peptides Containing Sugar Amino Acids Selectively Distinguishes and Inhibits Maturation of Pre-miRNAs of the Same Family

The discovery of microRNAs (miRNAs) has added a new dimension to the gene regulatory networks, making aberrantly expressed miRNAs as therapeutically important targets. Small molecules that can selectively target and modulate miRNA levels can thus serve as lead structures. Cationic cyclic peptides containing sugar amino acids represent a new class of small molecules that can target miRNA selectively. Upon treatment of these small molecules in breast cancer cell line, we profiled 96 therapeutically important miRNAs associated with cancer and observed that these peptides can selectively target paralogous miRNAs of the same seed family. This selective inhibition is of prime significance in cases when miRNAs of the same family have tissue-specific expression and perform different functions. During these conditions, targeting an entire miRNA family could lead to undesired adverse effects. The selective targeting is attributable to the difference in the three-dimensional structures of precursor miRNAs. Hence, the core structure of these peptides can be used as a scaffold for designing more potent inhibitors of miRNA maturation and hence function.

The physicochemical characteristics and anaerobic degradability of desiccated coconut industry waste water

Desiccated coconut industries (DCI) create various intermediates from fresh coconut kernel for cosmetic, pharmaceutical and food industries. The mechanized and non-mechanized DCI process between 10,000 and 100,000 nuts/day to discharge 6-150 m(3) of malodorous waste water leading to a discharge of 2646642 kg chemical oxygen demand (COD) daily. In these units, three main types of waste water streams are coconut kernel water, kernel wash water and virgin oil waste water. The effluent streams contain lipids (1-55 g/l), suspended solids (6-80 g/l) and volatile fatty acids (VFA) at concentrations that are inhibitory to anaerobic bacteria. Coconut water contributes to 20-50 % of the total volume and 50-60 % of the total organic loads and causes higher inhibition of anaerobic bacteria with an initial lag phase of 30 days. The lagooning method of treatment widely adopted failed to appreciably treat the waste water and often led to the accumulation of volatile fatty acids (propionic acid) along with long-chain unsaturated free fatty acids. Biogas generation during biological methane potential (BMP) assay required a 15-day adaptation time, and gas production occurred at low concentrations of coconut water while the other two streams did not appear to be inhibitory. The anaerobic bacteria can mineralize coconut lipids at concentrations of 175 mg/l; however; they are severely inhibited at a lipid level of = 350 mg/g bacterial inoculum. The modified Gompertz model showed a good fit with the BMP data with a simple sigmoid pattern. However, it failed to fit experimental BMP data either possessing a longer lag phase and/or diauxic biogas production suggesting inhibition of anaerobic bacteria.

Industry perceptions of barriers to commercialization of regenerative medicine products in the UK.

AIMS: Regenerative medicine is an emerging field with the potential to provide widespread improvement in healthcare and patient wellbeing via the delivery of therapies that can restore, regenerate or repair damaged tissue. As an industry, it could significantly contribute to economic growth if products are successfully commercialized. However, to date, relatively few products have reached the market owing to a variety of barriers, including a lack of funding and regulatory hurdles. The present study analyzes industry perceptions of the barriers to commercialization that currently impede the success of the regenerative medicine industry in the UK. MATERIALS & METHODS: The analysis is based on 20 interviews with leading industrialists in the field. RESULTS: The study revealed that scientific research in regenerative medicine is thriving in the UK. Unfortunately, lack of access to capital, regulatory hurdles, lack of clinical evidence leading to problems with reimbursement, as well as the culture of the NHS do not provide a good environment for the commercialization of regenerative medicine products. CONCLUSION: Policy interventions, including increased translational government funding, a change in NHS and NICE organization and policies, and regulatory clarity, would likely improve the general outcomes for the regenerative medicine industry in the UK.

Innovation processes within the healthcare industry: Determining critical success factors aligned to product strategies

The impact of differing product strategies on product innovation processes pursued by healthcare firms is discussed. The critical success factors aligned to product strategies are presented. A definite split between pioneering product strategies and late entrant product strategies is also recognised.

Período crítico de protección contra plagas del follaje y frutos del cultivo de la sandia (Citrullus vulgaris sugar baby) de exportación

Se hizo un experimento para determinar el efecto de periodos de protección de plagas del follajes y frutos sobre el rendimiento y la ganancia neta en el cultivo de sandía para exportación. el experimento fue ubicado entre Nagarote y la paz centro, realizándose en los meses de febrero a abril de 1988, bajo riego. Para la protección del cultivo de las plagas se utilizó el insecticida prfenofos más riopcord (tambo 880 ecu). La dinámica poblacional mostró que las plagas que provocaron daños directo a los frutos como larvas de spodoptera spp. (lepidóptera: noctuidae) y heliothis ssp. (Lepidóptera: noctuidae), se acentuaron desde los 40 días después de la emergencia (DDE) de las plantas hasta el final de la cosecha. Las plagas que afectaron principalmente los follajes como lyriomiza spp. (Díptera: agromizidae) y aphis spp. Homóptera: aphididae) fueron más constante pero que a partir de los 38 DDE aumentaron sus poblaciones y provocaron un daño severo. El tratamiento que fue protegido desde la emergencia de la planta hasta la cosecha ocupo el primer lugar en fruto/mz, pero sin diferencias significativas entre los periodo de protección a excepción del testigo (sin protección). Así también se colocó en el primer lugar en el número de cajas con frutos exportables por su tamaño/mz, pero sin diferencia significativas con los periodos protegidos desde los 19 y 43 DDE hasta la cosecha. El periodo protegido en ninguna fase de cultivo y el periodo protegido desde la emergencia hasta los 43 DDE ocuparon el primer lugar en fruto no exportable por su tamaño demasiado pequeño. El tratamiento protegido desde los 19 DDE hasta la cosecha presento la mayor ganancia neta. Se presentó deformación de frutos entre 70 y80 %, no presentándose efecto de periodo de protección.